Viewing Study NCT00269412


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
Study NCT ID: NCT00269412
Status: COMPLETED
Last Update Posted: 2019-11-25
First Post: 2005-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
Sponsor:
Organization: